Mutations of p53 in Barrett's esophagus and Barrett's cancer: A prospective study of ninety-eight cases

Journal of Thoracic and Cardiovascular Surgery

Volumn 111, Issue 2, 1996, Pages 323-333

  Schneider, P M ^a   Casson, A G ^a   Levin, B ^a   Garewal, H S ^a   Hoelscher, A H ^a   Becker, K ^a   Dittler, H J ^a   Cleary, K R ^a   Troster, M ^a   Siewert, J R ^a   Roth, J A ^a   Rice, T W ^a   Rusch, V W ^a   Trastek, V F ^a   Thomas, A N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGUS CARCINOMA; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METAPLASIA; PRECANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0030020089     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70441-5     Document Type: Article

References (46)

1. RW Sjogren LF. Johnson Barrett's esophagus: a review Am J Med 74 1983 313 320
2. SJ Spechler RK. Goyal Barrett's esophagus N Engl J Med 315 1987 362 371
3. B. Reid Barrett's esophagus and esophageal adenocarcinoma Gastroenterol Clin North Am 20 1991 817 834
4. SR Hamilton RR. Smith The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus Am J Clin Pathol 87 1987 301 312
5. NK Altorki DB. Skinner Adenocarcinoma in Barrett's esophagus Semin Surg Oncol 6 1990 274 278
6. WJ Blot SS Devesa RW Kneller JF Fraumeni Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
7. RC Haggitt J Tryzelaar FH Ellis H Colcher Adenocarcinoma complicating columnar epithelium–lined (Barrett's) esophagus Am J Clin Pathol 70 1978 1 5
8. W Hameeteman GN Tytgat HJ Houthoff JG. Van Den Tweel Barrett's esophagus: development of dysplasia and adenocarcinoma Gastroenterology 96 1989 1249 1256
9. BJ Reid PL Blount CE Rubin DS Levine RC Haggitt PS. Rabinovitch Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort Gastroenterology 102 1992 1212 1219
10. PS Rabinovitch BJ Reid RC Haggitt TH Norwood CE. Rubin Progression to cancer in Barrett's esophagus is associated with genomic instability Lab Invest 60 1 1988 65 71
11. WH Raskind T Norwood DS Levine RC Haggitt PS Rabinovitch BJ. Reid Persistent cloncal areas and expansion in Barrett's esophagus Cancer Res 52 1992 2946 2950
12. MB Fennerty RE Sampliner D Way R Riddell K Steinbrom HS. Garewal Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus Gastroenterology 97 1989 815 820
13. HS Garewal R Sampliner Y Liu JM. Trent Chromosomal rearrangement in Barrett's esophagus: a premalignant lesion of esophageal adenocarcinoma Cancer Genet Cytogenet 42 1989 281 286
14. PL Blount S Ramel WH Raskind 17 allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma Cancer Res 51 1991 5482 5486
15. PL Blount SJ Meltzer J Yin Y Huang MJ Krasna BJ. Reid Clonal ordering of 17p and 5q allelic losses in barrett dysplasia and adenocarcinoma Proc Natl Acad Sci U S A 90 1993 3221 3225
16. CC Harris M. Hollstein Clinical implications of the p53 tumor-suppressor gene N Engl J Med 329 1993 1318 1327
17. B Vogelstein KW. Kinzler p53 functions and dysfunction Cell 70 1992 523 526
18. M Hollstein D Sidransky B Vogelstein CC. Harris p53 mutations in human cancers Science 253 1991 49 53
19. MC Hollstein RA Metcalf JA Welsh R Montesano CC. Harris Frequent mutation of the p53 gene in human esophageal cancer Proc Natl Acad Sci U S A 87 1990 9958 9961
20. T Wagata I Shibagaki M Imamura Loss of 17 p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas Cancer Res 53 1993 846 850
21. AG Casson T Mukhopadhyay KR Cleary JY Ro B Levin JA. Roth p53 gene mutations in Barrett's epithelium and esophageal cancer Cancer Res 51 1991 4495 4499
22. K Neshat CA Sanchez PC Galipeau p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia Gastroenterology 106 1994 1589 1595
23. S Ramel BJ Reid CA Sanchez Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry Gastroenterology 102 1992 1220 1228
24. M Younes RM Lebovitz LV Lechago J. Lechago p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study Gastroenterology 105 1993 1637 1642
25. RH. Riddell Dysplasia and regression in Barrett's epithelium SJ Spechler RK Goyal Barrett's esophagus. 1985 Elsevier New York 224 229
26. WA Williamson FH Ellis SP. Gibb Barrett's esophagus: prevalence and incidence of adenocarcinoma Arch Intern Med 151 1991 2212 2216
27. JM Streitz FH Ellis SP Gibb K Balogh E. Watkins Adenocarcinoma in Barrett's esophagus: a clinicopathologic study of 65 cases Ann Surg 213 1991 122 125
28. JM Nigro SJ Baker AC Preisinger Mutations in the p53 gene occur in diverse human tumor types Nature 342 1989 705 708
29. J Imamura CB Bartram F Berthold D Harms H Nakamura HP. Koeffler Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification Cancer Res 53 1993 4053 4058
30. L Spinardi R Mazars C. Theillet Protocols for an improved detection of point mutations by SSCP Nucleic Acids Res 19 1991 4009
31. PC. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
32. Y Huang RF Boynton PL Blount Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers Cancer Res 52 1992 6525 6530
33. KY Chung T Mukhopadhyay J Kim Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract Cancer Res 53 1993 1676 1683
34. WP Bennett MC Hollstein RA Metcalf p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 52 1992 6092 6097
35. DP Slaughter HW Southwick W Smejkal “Field cancerization” in oral stratified squamous epithelium Cancer 6 1953 963 968
36. TW Rice JR Goldblum GW Falk RR Tubbs TJ Kirby G Casey p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma J THORAC CARDIOVASC SURG 108 1994 1132 1137
37. DR Jones AG Davidson CL Summers GF Murray DC. Quinlan Potential application of p53 as an intermediate biomarker in Barrett's esophagus Ann Thorac Surg 57 1994 598 603
38. J Milner JV. Watson Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein Oncogene 5 1990 1683 1690
39. DF. Spandau Distinct conformations of p53 are observed at different stages of keratinocyte differentiation Oncogene 9 1994 1861 1868
40. IC Hsu RA Metcalf T Sun JA Welsh NJ Wang CC. Harris Mutational hotspot in the p53 gene in human hepatocellular carcinomas Nature 350 1991 427 428
41. B Renault M Van den Broek R Fodde Base traditions are the most frequent genetic change at p53 in gastric cancer Cancer Res 53 1993 2614 2617
42. WM Rideout 3rd GA Coetzee AF Olumi PA. Jones 5-Methylcytosine as an endogenous mutagen in the LDL receptor and p53 genes Science 249 1990 1288 1290
43. MN Routledge DA Wink IK Keefer A. Dipple Mutations induced by saturated aqueous nitric oxide in the pSP189 supF gene in human Ad293 and E. coli MBM7070 cells Carcinogenesis 14 1993 1251 1254
44. NK Boughton-Smith SM Evans CJ Hawkey Nitric oxide synthase activity in ulcerative colitis and Crohn's disease Lancet 342 1993 338 340
45. SJ Middleton M Shorthouse JO. Hunter Increase nitric oxide synthesis in ulcerative colitis Lancet 341 1993 465 466
46. A. Ekbom Ulcerative colitis and colorectal cancer: a population based study N Engl J Med 323 1990 1228 1233